PRESS RELEASE: FILAMENT HEALTH ANNOUNCES CHANGE TO BOARD OF DIRECTORS
PRESS RELEASE: FILAMENT HEALTH ANNOUNCES CHANGE TO BOARD OF DIRECTORS
VANCOUVER, BC, Jan. 2, 2024 /CNW/ – Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) (FSE: 7QS) (“Filament” or the “Company”), a clinical-stage natural psychedelic drug development company, today announced that Maureen O’Connell has stepped down from her position as Director and Audit Committee Chair on the Company’s board of directors, effective December 31, 2023. O’Connell commented: “I have been part of […]
Go to Source
Powered by WPeMatico